Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Exercise Periodization and Older Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03443375
Recruitment Status : Completed
First Posted : February 23, 2018
Last Update Posted : February 23, 2018
Sponsor:
Information provided by (Responsible Party):
Hélio José Coelho Júnior, University of Campinas, Brazil

Brief Summary:
The present study aimed at investigating the effects of two different resistance training protocols — nonperiodized (NP) and daily undulating periodization (DUP) — on hemodynamic, morphofunctional and cognitive parameters of robust older women. Methods: Forty-two older women were randomized allocated into one of the three experimental groups: NP, DUP, and control group (CG). Evaluations of the hemodynamic, morphofunctional and cognitive parameters occurred before, during and after six months. The exercise groups performed the program of exercise twice a week over 22 weeks. In NP, the two weekly sessions were based on 3 sets of 8-10 repetitions at a difficult intensity. However, in DUP, a power exercise session based on 3 sets of 8-10 repetitions at a moderate intensity was added in the first session of the week.

Condition or disease Intervention/treatment Phase
Aging Physical Activity Sarcopenia Cognitive Decline Blood Pressure Physical Disability Other: Physical exercise Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 14 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Other
Official Title: Effects of Resistance Training Periodization on Hemodynamic, Morphofunctional and Cognitive Parameters of Robust Older Women.
Actual Study Start Date : January 2015
Actual Primary Completion Date : December 2015
Actual Study Completion Date : December 2015

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Nonperiodized resistance training
The Nonperiodized group performed was an intervention based on resistance exercise program with a constant intensity.
Other: Physical exercise
The interventions proposed in the present trial were based on a safe and well-established exercise training program

Experimental: Daily undulating periodized
The Daily undulating periodized program was an intervention based on daily alterations on exercise load. .
Other: Physical exercise
The interventions proposed in the present trial were based on a safe and well-established exercise training program

No Intervention: Control group
The control group remained their regular habits of life during all study period, without engaging in physical exercise programs.



Primary Outcome Measures :
  1. Changes in transfer capacity in seconds [ Time Frame: 6 months ]
    TUG performance


Secondary Outcome Measures :
  1. Changes in fat-free mass in kg [ Time Frame: 6 months ]
    Fat-free mass

  2. Changes in overall cognitive capacity in points [ Time Frame: 6 months ]
    MEEM

  3. Changes in blood pressure in mmHg [ Time Frame: 6 months ]
    Blood Pressure

  4. Changes in shor-term memory in points [ Time Frame: 6 months ]
    Memory



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   60 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Aged ≥60 years;
  • Female;
  • Not having been part of a systematic program of physical exercises in the last 6 months;
  • MEEM score >19 points;
  • Kihon checklist score >10 points;
  • Capacity to perform the basic and instrumental activities of daily living according to Katz and Pfeffer indexes;
  • Self-reported good memory;
  • Complete all measurements.

Exclusion Criteria:

  • Changes on antihypertensive medication in the past 6 months prior to inclusion in the study;
  • Cardiovascular disease (i.e., acute myocardial infarction, stroke, peripheral arterial disease, and transient ischemic disease)
  • Metabolic disease (i.e., diabetes mellitus type I or II), pulmonary disease (i.e., emphysema)
  • Neurological and/or psychiatric disease (i.e., Parkinson's or Alzheimer's disease)
  • Skeletal muscle disorders
  • Comorbidities associated with greater risk of falls
  • Recent history of smoking or alcohol abuse
  • Hormone replacement therapy and/or psychotropic drugs.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Hélio José Coelho Júnior, Mr. Coelho-Junior, University of Campinas, Brazil
ClinicalTrials.gov Identifier: NCT03443375     History of Changes
Other Study ID Numbers: 835.733
First Posted: February 23, 2018    Key Record Dates
Last Update Posted: February 23, 2018
Last Verified: February 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Hélio José Coelho Júnior, University of Campinas, Brazil:
Older adults
Physical function
Muscle mass
Short-term memory
Executive function
Blood Pressure
Resistance training
Exercise training
Periodization

Additional relevant MeSH terms:
Layout table for MeSH terms
Sarcopenia
Cognitive Dysfunction
Muscular Atrophy
Neuromuscular Manifestations
Neurologic Manifestations
Nervous System Diseases
Atrophy
Pathological Conditions, Anatomical
Signs and Symptoms
Cognition Disorders
Neurocognitive Disorders
Mental Disorders